Ardelyx ARDX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Product | ||||||
| IBSRELA | $70.07M-19.1% | $86.6M+10.8% | $78.16M+20.2% | $65.05M+46.5% | $44.4M-17.5% | |
| Licensing revenue | $51K+122% | $23K-8.0% | $25K+25.0% | $20K-99.6% | $5.02M+22,718% | |
| Non-cash royalty revenue related to the sale of future royalties | $695K-48.5% | $1.35M-99.7% | $500M+36,132% | $1.38M+34.5% | $1.03M+12.0% | |
| Product supply revenue | $354K-96.3% | $9.44M— | $0-100% | $6.19M+2,335% | $254K-93.9% | |
| XPHOZAH | $23.3M-16.2% | $27.8M+1.6% | $27.36M+9.3% | $25.03M+6.9% | $23.41M-59.0% | |
| Cost of Sales by Product | ||||||
| Other cost of revenue | $1.94M-75.5% | $7.91M+499% | $1.32M-85.6% | $9.16M-8.1% | $9.96M-35.9% | |
| Product sales, net | $2.88M-2.1% | $2.94M+10.4% | $2.66M-18.0% | $3.25M+38.7% | $2.34M-13.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Ardelyx break its business down?
- Ardelyx (ARDX) reports total revenues by product across 5 parts — IBSRELA, Licensing revenue, Non-cash royalty revenue related to the sale of future royalties, Product supply revenue and XPHOZAH. Each is extracted from the segment footnotes and tracked over time.
- Where does Ardelyx's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Ardelyx's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
